Platelet-derived growth factor (PDGF)-C inhibits neuroretinal apoptosis in a murine model of focal retinal degeneration

Laboratory Investigation

Volumn 94, Issue 6, 2014, Pages 674-682

  Wang, Yujuan ^a,b   Abu Asab, Mones S ^c   Yu, Cheng Rong ^a   Tang, Zhongshu ^b   Shen, Defen ^a   Tuo, Jingsheng ^a   Li, Xuri ^b   Chan, Chi Chao ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c NATIONAL EYE INSTITUTE   (United States)

Author keywords

age related macular degeneration; apoptosis; neuroprotection; platelet derived growth factor C; retina

Indexed keywords

PHOSPHATE BUFFERED SALINE; PLATELET DERIVED GROWTH FACTOR C; RECOMBINANT PLATELET DERIVED GROWTH FACTOR CC; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HISTOPATHOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NEUROPROTECTION; NONHUMAN; OPHTHALMOSCOPY; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA DEGENERATION;

ANIMALS; APOPTOSIS; LYMPHOKINES; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; PLATELET-DERIVED GROWTH FACTOR; RETINA; RETINAL DEGENERATION;

EID: 84904189263     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.60     Document Type: Article

References (61)

1. Li X, Ponten A, Aase K, et al. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2000;2:302-309.
2. Kazlauskas A. A new member of an old family. Nat Cell Biol 2000;2:E78-E79.
3. Li X, Eriksson U. Novel PDGF family members: PDGF-C and PDGF-D. Cytokine Growth Factor Rev 2003;14:91-98.
4. Fredriksson L, Ehnman M, Fieber C, et al. Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator. J Biol Chem 2005;280:26856-26862.
5. Lee C, Zhang F, Tang Z, et al. PDGF-C: a new performer in the neurovascular interplay. Trends Mol Med 2013;19:474-486.
6. Cao R, Brakenhielm E, Li X, et al. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFRalphaalpha and -alphabeta receptors. FASEB J 2002;16:1575-1583.
7. Gilbertson DG, Duff ME, West JW, et al. Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J Biol Chem 2001;276:27406-27414.
8. Ding H, Wu X, Bostrom H, et al. A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling. Nat Genet 2004;36: 1111-1116.
9. Karvinen H, Rutanen J, Leppanen O, et al. PDGF-C and -D and their receptors PDGFR-alpha and PDGFR-beta in atherosclerotic human arteries. Eur J Clin Invest 2009;39:320-327.
10. Su EJ, Fredriksson L, Geyer M, et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 2008;14:731-737.
11. Crawford Y, Kasman I, Yu L, et al. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 2009;15:21-34.
12. Tang Z, Arjunan P, Lee C, et al. Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3beta phosphorylation. J Exp Med 2010;207:867-880.
13. Lei H, Hovland P, Velez G, et al. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 2007;48:2335-2342.
14. Hamada T, Ui-Tei K, Imaki J, et al. The expression of SCDGF/PDGF-C/ fallotein and SCDGF-B/PDGF-D in the rat central nervous system. Mech Dev 2002;112:161-164.
15. Li R, Maminishkis A, Wang FE, et al. PDGF-C and -D induced proliferation/migration of human RPE is abolished by inflammatory cytokines. Invest Ophthalmol Vis Sci 2007;48:5722-5732.
16. Li X, Tjwa M, Moons L, et al. Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors. J Clin Invest 2005;115:118-127.
17. Greenberg JI, Shields DJ, Barillas SG, et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 2008;456:809-813.
18. Hou X, Kumar A, Lee C, et al. PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets. Proc Natl Acad Sci USA 2010;107:12216-12221.
19. Coleman HR, Chan CC, Ferris 3rd FL, et al. Age-related macular degeneration. Lancet 2008;372:1835-1845.
20. Klein R, Chou CF, Klein BE, et al. Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol 2011;129:75-80.
21. Lim LS, Mitchell P, Seddon JM, et al. Age-related macular degeneration. Lancet 2012;379:1728-1738.
22. Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruchs membrane/choriocapillaris complex. Mol Aspects Med 2012;33:295-317.
23. Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci 1996;37:1236-1249.
24. Curcio CA. Photoreceptor topography in ageing and age-related maculopathy. Eye (Lond) 2001;15:376-383.
25. de Jong PT. Age-related macular degeneration. N Engl J Med 2006;355:1474-1485.
26. Colak E, Majkic-Singh N, Zoric L, et al. The impact of inflammation to the antioxidant defense parameters in AMD patients. Aging Clin Exp Res 2012;24:588-594.
27. Xu H, Chen M, Forrester JV. Para-inflammation in the aging retina. Prog Retin Eye Res 2009;28:348-368.
28. Rutar M, Natoli R, Kozulin P, et al. Analysis of complement expression in light-induced retinal degeneration: synthesis and deposition of C3 by microglia/macrophages is associated with focal photoreceptor degeneration. Invest Ophthalmol Vis Sci 2011;52:5347-5358.
29. Kauppinen A, Niskanen H, Suuronen T, et al. Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells-implications for age-related macular degeneration (AMD). Immunol Lett 2012;147:29-33.
30. Wang Y, Wang VM, Chan CC. The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Eye 2011;25: 127-139.
31. Tarallo V, Hirano Y, Gelfand BD, et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 2012;149:847-859.
32. Ambati J, Fowler BJ. Mechanisms of age-related macular degeneration. Neuron 2012;75:26-39.
33. Ardeljan D, Chan CC. Aging is not a disease: Distinguishing age-related macular degeneration from aging. Prog Retin Eye Res 2013;37: 68-89.
34. Dunaief JL, Dentchev T, Ying GS, et al. The role of apoptosis in age-related macular degeneration. Arch Ophthalmol 2002;120: 1435-1442.
35. Yang P, Wiser JL, Peairs JJ, et al. Human RPE expression of cell survival factors. Invest Ophthalmol Vis Sci 2005;46:1755-1764.
36. Chu XK, Wang Y, Ardeljan D, et al. Controversial view of a genetically altered mouse model of focal retinal degeneration. Bioengineered 2012;4:130-135.
37. Ramkumar HL, Zhang J, Chan CC. Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). Prog Retin Eye Res 2010;29:169-190.
38. Tuo J, Bojanowski CM, Zhou M, et al. Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest Ophthalmol Vis Sci 2007;48:3827-3836.
39. Chan CC, Ross RJ, Shen D, et al. Ccl2/Cx3cr1-deficient mice: an animal model for age-related macular degeneration. Ophthalmic Res 2008;40: 124-128.
40. Mattapallil MJ, Wawrousek EF, Chan CC, et al. The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci 2012;53:2921-2927.
41. Chen M, Hombrebueno JR, Luo C, et al. Age- and light-dependent development of localised retinal atrophy in CCL2(-/-)CX3CR1(GFP/GFP) mice. PLoS One 2013;8:e61381.
42. Yu CR, Lin JX, Fink DW, et al. Differential utilization of Janus kinasesignal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha. J Immunol 1996;157:126-137.
43. Tuo J, Pang JJ, Cao X, et al. AAV5-mediated sFLT01 gene therapy arrests retinal lesions in Ccl2(-/-)/Cx3cr1(-/-) mice. Neurobiol Aging 2012;33:433e431-410.
44. Tuo J, Cao X, Shen D, et al. Anti-inflammatory recombinant TSG-6 stabilizes the progression of focal retinal degeneration in a murine model. J Neuroinflammation 2012;9:59.
45. Li Y, Song Y, Zhao L, et al. Direct labeling and visualization of blood vessels with lipophilic carbocyanine dye DiI. Nat Protoc 2008;3: 1703-1708.
46. Ben-Shabat S, Parish CA, Hashimoto M, et al. Fluorescent pigments of the retinal pigment epithelium and age-related macular degeneration. Bio-org Med Chem Lett 2001;11:1533-1540.
47. Karan G, Lillo C, Yang Z, et al. Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration. Proc Natl Acad Sci USA 2005;102:4164-4169.
48. Parish CA, Hashimoto M, Nakanishi K, et al. Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium. Proc Natl Acad Sci USA 1998;95:14609-14613.
49. Delori FC, Goger DG, Dorey CK. Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest Ophthalmol Vis Sci 2001;42:1855-1866.
50. Wolf G. Lipofuscin and macular degeneration. Nutr Rev 2003; 61:342-346.
51. Ding X, Patel M, Shen D, et al. Enhanced HtrA2/Omi expression in oxidative injury to retinal pigment epithelial cells and murine models of neurodegeneration. Invest Ophthalmol Vis Sci 2009;50: 4957-4966.
52. Wang Y, Shen D, Wang VM, et al. Enhanced apoptosis in retinal pigment epithelium under inflammatory stimuli and oxidative stress. Apoptosis 2012;17:1144-1155.
53. Cao X, Liu M, Tuo J, et al. The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2/Cx3cr1 double deficient mice. Exp Eye Res 2010;91:15-25.
54. Basu A, Haldar S. The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod 1998;4:1099-1109.
55. Mikhailov V, Mikhailova M, Pulkrabek DJ, et al. Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J Biol Chem 2001;276:18361-18374.
56. Ku B, Liang C, Jung JU, et al. Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX. Cell Res 2011;21:627-641.
57. Liang MH, Chuang DM. Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival. J Biol Chem 2007;282: 3904-3917.
58. Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 2005;7:452-464.
59. Bandopadhyay R, Orte C, Lawrenson JG, et al. Contractile proteins in pericytes at the blood-brain and blood-retinal barriers. J Neurocytol 2001;30:35-44.
60. Li X, Kumar A, Zhang F, et al. VEGF-independent angiogenic pathways induced by PDGF-C. Oncotarget 2010;1:309-314.
61. di Tomaso E, London N, Fuja D, et al. PDGF-C induces maturation of blood vessels in a model of glioblastoma and attenuates the response to anti-VEGF treatment. PLoS ONE 2009;4:e5123.